Holland Capital’s Quantib has been Acquired by RadNet
TM Capital served as exclusive financial advisor to Quantib B.V., a portfolio company of Holland Capital, in connection with its sale to RadNet, Inc.
TM Capital served as exclusive financial advisor to Quantib B.V., a portfolio company of Holland Capital, in connection with its sale to RadNet, Inc.
TM Capital assisted The MedTech Group in completing a recapitalization with KRG Capital Partners to accelerate growth and provide shareholder liquidity
TM Capital assisted SteriGenics International, Inc. (NASDAQ) in acquiring the business and assets of RTI, Inc.
TM Capital advised Surpass Medical, Ltd. in its sale to Stryker Corporation (NYSE:SYK) for $135 million in cash and future consideration